Skip to main content

Advertisement

Log in

Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis and the plasmatic and salivary levels of RANKL and Survivin: a short-term clinical study

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Aim

To investigate the influence of nonsurgical periodontal treatment (NSPT) on clinical periodontal status, rheumatoid arthritis (RA) activity, and plasmatic and salivary levels of biomarkers through a controlled clinical trial on individuals with RA and periodontitis (PE).

Methods

Sixty-six individuals from a convenience sample were considered eligible and consecutively allocated in 3 groups: (1) individuals without PE and RA (-PE-RA, n = 19); (2) individuals without PE and with RA (-PE+RA, n = 23), and (3) individuals with PE and RA (+PE+RA, n = 24). Full-mouth periodontal clinical examinations, Disease Activity Score (DAS-28) evaluations, and analysis in plasma and saliva of RANKL, OPG, RANKL/OPG, and Survivin were performed at baseline (T1) and 45 days after NSPT (T2).

Results

NSPT in the +PE+RA group was very effective to improve periodontal condition. At T2, significant reductions in DAS-28 were observed in +PE+RA (p = 0.011). Significantly higher levels of Survivin and RANKL were observed in saliva and plasma from RA individuals (with and without PE) compared to controls. Additionally, Survivin e RANKL demonstrated positive correlations with DAS-28 and an expressively significant reduction in +PE+RA at T2 (p < 0.001).

Conclusions

NSPT was effective on improving both the periodontal and the RA clinical status and reducing the concentration of Survivin and RANKL in saliva and plasma.

Practical implications

Nonsurgical periodontal treatment was effective on reducing the concentration of Survivin and RANKL and on improving both the periodontal and the RA clinical status of affected individuals.

Trial registration

Brazilian Registry of Clinical Trials (ReBEC) protocol #RBR-8g2bc8 (http://www.ensaiosclinicos.gov.br/rg/RBR-8g2bc8/).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hajishengallis G (2015) Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 15:30–44. https://doi.org/10.1038/nri3785

    Article  PubMed  PubMed Central  Google Scholar 

  2. Figueredo CM, Alves JC, Beiler TFCSB, Fischer RG (2019) Anti-apoptotic traits in gingival tissue from patients with severe generalized chronic periodontitis. J Investig Clin Dent:e12422. https://doi.org/10.1111/jicd.12422

  3. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361

    Article  Google Scholar 

  4. Li S, Schmalz G, Schmidt J, Krause F, Haak R, Ziebolz D (2018) Antimicrobial peptides as a possible interlink between periodontal diseases and its risk factors: a systematic review. J Periodontal Res 53:145–155

    Article  Google Scholar 

  5. Kinane DF, Preshaw PM, Loos BG, Working Group 2 of Seventh European Workshop on Periodontology (2011) Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 38(S-11):44–48. https://doi.org/10.1111/j.1600-051X.2010.01682.x

    Article  PubMed  Google Scholar 

  6. Yuce HB, Gokturk O, Turkal HA, Inanir A, Benli I, Demir O (2017) Assessment of local and systemic 25-hydroxy-vitamin D, RANKL, OPG, and TNF levels in patients with rheumatoid arthritis and periodontitis. J Oral Sci 59:397–404

    Article  Google Scholar 

  7. Culshaw S, McInnes IB, Liew FY (2011) What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? J Clin Periodontol 38:S106–S113. https://doi.org/10.1111/j.1600-051X.2010.01669.x

    Article  Google Scholar 

  8. Genco RJ, Sanz M (2020) Clinical and public health implications of periodontal and systemic diseases: an overview. Periodontol 83:7–13. https://doi.org/10.1111/prd.12344

    Article  Google Scholar 

  9. Ochanji AA, Matu NK, Mulli TK (2017) Association of salivary RANKL and osteoprotegerin levels with periodontal health. Clin Exp Dent Res 3:45–50. https://doi.org/10.1002/cre2.49

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yan K, Lin Q, Tang K et al (2020) Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio. BMC Oral Health 20:27. https://doi.org/10.1186/s12903-020-1017-9

    Article  PubMed  PubMed Central  Google Scholar 

  11. Romas E, Gillespie MT, Martin TJ (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340–346

    Article  Google Scholar 

  12. Danks L, Komatsu N, Guerrini MM, Guerrini MM, Sawa S, Armaka M, Kollias G, Nakashima T, Takayanagi H (2015) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75:1187–1195. https://doi.org/10.1136/annrheumdis-2014-207137

    Article  PubMed  Google Scholar 

  13. Belibasakis GN, Bostanci N (2012) The RANKL-OPG system in clinical periodontology. J Clin Periodontol 39:239–248. https://doi.org/10.1111/j.1600-051X.2011.01810.x

    Article  PubMed  Google Scholar 

  14. Baltacıoğlu E, Kehribar MA, Yuva P, Alver A, Atagün ÖS, Karabulut E, Akalın FA (2014) Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis. J Periodontol 85:317–326. https://doi.org/10.1902/jop.2013.130012

    Article  PubMed  Google Scholar 

  15. Gravina G, Wasén C, Garcia-Bonete MJ, Turkkila M, Erlandsson MC, Töyrä Silfverswärd S, Brisslert M, Pullerits R, Andersson KM, Katona G, Bokarewa MI (2017) Survivin in autoimmune diseases. Autoimmun Rev 16:845–855. https://doi.org/10.1016/j.autrev.2017.05.016

    Article  PubMed  Google Scholar 

  16. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med 8:917–921. https://doi.org/10.1038/nm0897-917

    Article  Google Scholar 

  17. Bokarewa M, Lindblad S, Bokarew D, Tarkowski A (2005) Balance between Survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther 7:R349–R358

    Article  Google Scholar 

  18. Svensson B, Hafstrom I, Erlandsson MC, Forslind K, Bokarewa MI (2014) Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of Survivin in early rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 16:R12

    Article  Google Scholar 

  19. Khodashahi M, Saadati N, Sahebari M, Rezaieyazdi Z, Rastgou N (2020) Diagnostic role of Survivin in rheumatoid arthritis: a systematic review. Curr Rheumatol Rev 15:267–279. https://doi.org/10.2174/1573397116666200116095039

    Article  Google Scholar 

  20. Lucas H, Bartold PM, Dharmapatni AASSK, Holding CA, Haynes DR (2010) Inhibition of apoptosis in periodontitis. J Dent Res 89:29–33. https://doi.org/10.1177/0022034509350708

    Article  PubMed  Google Scholar 

  21. Johnson RB, Wikle JC (2014) Sex differences in inflammatory and apoptotic signaling molecules in normal and diseased human gingiva. J Periodontol 85:1612–1619. https://doi.org/10.1902/jop.2014.130718

    Article  PubMed  Google Scholar 

  22. Zhao R, Gu C, Zhang Q, Zhou W, Feng G, Feng X, Dong C, Gu Z (2019) Periodontal disease in Chinese patients with rheumatoid arthritis: a case-control study. Oral Dis 25:2003–2009. https://doi.org/10.1111/odi.13176

    Article  PubMed  Google Scholar 

  23. Browne RW, Kantarci A, LaMonte MJ et al (2013) Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One 8:e59498. https://doi.org/10.1371/journal.pone.0059498

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lahdentausta LSJ, Paju S, Mäntylä P et al (2018) Saliva and serum biomarkers in periodontitis and coronary artery disease. J Clin Periodontol 45:1045–1055. https://doi.org/10.1111/jcpe.12976

    Article  PubMed  Google Scholar 

  25. Biyikoglu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoglu E, Kinane DF (2013) Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int 33:2607–2616

    Article  Google Scholar 

  26. Cosgarea R, Tristiu R, Dumitru RB, Arweiler NB, Rednic S, Sirbu CI, Lascu L, Sculean A, Eick S (2019) Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis. Clin Oral Investig 23:141–151. https://doi.org/10.1007/s00784-018-2420-3

    Article  PubMed  Google Scholar 

  27. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  Google Scholar 

  28. Nesse W, Abbas F, van der Ploeg I, Spijkervet FKL, Dijkstra PU, Vissink A (2008) Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 35:668–673. https://doi.org/10.1111/j.1600-051X.2008.01249.x

    Article  PubMed  Google Scholar 

  29. Hujoel PP, White BA, García RI, Listgarten MA (2001) The dentogingival epithelial surface area revisited. J Periodontal Res 36:48–55

    Article  Google Scholar 

  30. Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol 89:S159–S172

    Article  Google Scholar 

  31. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584.2010

    Article  Google Scholar 

  32. Quirynen M, Mongardini C, De Soete M et al (2000) The role of chlorhexidine in the treatment of patients with advanced adult periodontitis. J Clin Periodontol 27:578–589

    Article  Google Scholar 

  33. Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Slowey PD, Almas K (2016) Human saliva collection devices for proteomics: an update. Int J Mol Sci 17:846

    Article  Google Scholar 

  34. Nesse W, Westra J, van der Wal JE et al (2012) The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol 39:599–607. https://doi.org/10.1111/j.1600-051X.2012.01885.x

    Article  PubMed  Google Scholar 

  35. Reichert S, Schlumberger W, Dähnrich C, Hornig N, Altermann W, Schaller HG, Schulz S (2015) Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of rheumatoid arthritis: a case control study. J Transl Med 13:283

    Article  Google Scholar 

  36. Schmickler J, Rupprecht A, Patschan S, Patschan D, Müller GA, Haak R, Mausberg RF, Schmalz G, Kottmann T, Ziebolz D (2017) Cross-sectional evaluation of periodontal status, microbiological and rheumatoid parameters in a large cohort of patients with rheumatoid arthritis. J Periodontol 88:368–379. https://doi.org/10.1902/jop.2016.160355

    Article  PubMed  Google Scholar 

  37. Cheah CW, Al-Maleki AR, Vadivelu J et al (2020) Salivary and serum cathelicidin LL-37 levels in subjects with rheumatoid arthritis and chronic periodontitis. Int J Rheum Dis 00:1–9. https://doi.org/10.1111/1756-185X.13919

    Article  Google Scholar 

  38. Pockpa AD, Soueidan A, Louis P, Coulibaly NT, Badran Z, Struillou X (2018) Twenty years of full-mouth disinfection: the past, the present and the future. Open Dent J 31:435–442. https://doi.org/10.2174/1874210601812010435

    Article  Google Scholar 

  39. Lappin DF, Apatzidou D, Quirke A-M, Oliver-Bell J, Butcher JP, Kinane DF, Riggio MP, Venables P, McInnes IB, Culshaw S (2013) Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol 40:907–915. https://doi.org/10.1111/jcpe.12138

    Article  PubMed  Google Scholar 

  40. Khare N, Vanza B, Sagar D, Saurav K, Chauhan R, Mishra S (2016) Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis: a case-control study. J Contemp Dent Pract 17:484–488

    Article  Google Scholar 

  41. Hussain SB, Botelho J, Machado V, Zehra SA, Mendes JJ, Ciurtin C, Orlandi M, D’Aiuto F (2020) Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis. Semin Arthritis Rheum 50:414–422. https://doi.org/10.1016/j.semarthrit.2020.01.009

    Article  PubMed  Google Scholar 

  42. Loutan L, Alpizar-Rodriguez D, Courvoisier DS, Finckh A, Mombelli A, Giannopoulou C (2019) Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis. J Clin Periodontol 46:690–698. https://doi.org/10.1111/jcpe.13117

    Article  PubMed  Google Scholar 

  43. Routsias JG, Goules JD, Goules A, Charalampakis G, Pikazis D (2011) Autopathogenic correlation of periodontitis and rheumatoid arthritis. Rheumatol 50:1189–1193. https://doi.org/10.1093/rheumatology/ker090

    Article  Google Scholar 

  44. Urnowey S, Ansai T, Bitko V, Nakayama K, Takehara T, Barik S (2006) Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: potential role of bacterial proteases in host signalling. BMC Microbiol 8:6–6. https://doi.org/10.1186/s12866-019-1608-2

    Article  Google Scholar 

  45. Gamonal J, Bascones A, Acevedo A, Blanco E, Silva A (2001) Apoptosis in chronic adult periodontitis analyzed byin situDNA breaks, electron microscopy, and immunohistochemistry. J Periodontol 72:517–525. https://doi.org/10.1902/jop.2001.72.4.517

    Article  PubMed  Google Scholar 

  46. Bradley EW, Ruan MM, Oursler MJ (2008) PAK1 is a novel MEK-independent raf target controlling expression of the IAP Survivin in M-CSF-mediated osteoclast survival. J Cell Physiol 217:752–758. https://doi.org/10.1002/jcp.21550

    Article  PubMed  PubMed Central  Google Scholar 

  47. Dharmapatni AA, Smith MD, Findlay DM et al (2009) Elevated expression of caspase-3 inhibitors, Survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther 11:R13

    Article  Google Scholar 

  48. Behfarnia P, Saied-Moallemi Z, Javanmard SH, Naseri R (2016) Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis. Adv Biomed Res 5:80. https://doi.org/10.4103/2277-9175.180992

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by grants from the National Council of Scientific and Technological Development – CNPq, Brasília, Brazil (Productivity research grant #402158/2016-4).

Author information

Authors and Affiliations

Authors

Contributions

All authors have made substantial contributions to the conception and design of the study. MFM, TAS, SRO, FQC, JRC, and FOC have been involved in data collection and data analysis. MFM, TAS, SRO, FQC, GAF, LOMC, SCC, JRC, and FOC have been involved in data interpretation, drafting the manuscript and critically revising it, having given their final approval on the version to be published.

Corresponding author

Correspondence to Fernando Oliveira Costa.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare no competing interests.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moura, M.F., Silva, T.A., Cota, L.O.M. et al. Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis and the plasmatic and salivary levels of RANKL and Survivin: a short-term clinical study. Clin Oral Invest 25, 6643–6652 (2021). https://doi.org/10.1007/s00784-021-03950-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-021-03950-4

Keywords

Navigation